Audit 405089

FY End
2025-09-30
Total Expended
$261.01M
Findings
2
Programs
81
Organization: Beth Israel Lahey Health, Inc. (MA)
Year: 2025 Accepted: 2026-06-26
Auditor: KPMG LLP

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
1219153 2025-001 Material Weakness Yes B
1219154 2025-001 Material Weakness Yes B

Programs

ALN Program Spent Major Findings
93.RD8 RESEARCH AND DEVELOPMENT $7.19M Yes 0
93.493 CONGRESSIONAL DIRECTIVES $2.00M Yes 0
93.083 PREVENTION OF DISEASE, DISABILITY, AND DEATH THROUGH IMMUNIZATION AND CONTROL OF RESPIRATORY AND RELATED DISEASES $1.98M Yes 0
93.273 ALCOHOL RESEARCH PROGRAMS $1.81M Yes 0
93.384 ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H) $1.29M Yes 0
93.696 CERTIFIED COMMUNITY BEHAVIORAL HEALTH CLINIC EXPANSION GRANTS $993,979 Yes 0
81.RD2 RESEARCH AND DEVELOPMENT $702,340 Yes 0
93.310 TRANS-NIH RESEARCH SUPPORT $665,417 Yes 0
93.186 NATIONAL RESEARCH SERVICE AWARD IN PRIMARY CARE MEDICINE $553,474 Yes 0
12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT $467,109 Yes 0
12.910 RESEARCH AND TECHNOLOGY DEVELOPMENT $376,144 Yes 0
43.001 SCIENCE $367,581 Yes 0
43.003 EXPLORATION $345,306 Yes 0
93.242 MENTAL HEALTH RESEARCH GRANTS $335,459 Yes 0
11.307 ECONOMIC ADJUSTMENT ASSISTANCE $331,079 Yes 0
93.215 HANSEN'S DISEASE NATIONAL AMBULATORY CARE PROGRAM $313,342 Yes 0
93.RD5 RESEARCH AND DEVELOPMENT $309,188 Yes 0
93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS $253,429 Yes 0
93.788 OPIOID STR $227,183 Yes 0
93.865 CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH $171,762 Yes 0
93.867 VISION RESEARCH $168,535 Yes 0
93.846 ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH $162,001 Yes 0
21.027 CORONAVIRUS STATE AND LOCAL FISCAL RECOVERY FUNDS $152,299 Yes 0
93.918 GRANTS TO PROVIDE OUTPATIENT EARLY INTERVENTION SERVICES WITH RESPECT TO HIV DISEASE $151,437 Yes 0
93.395 CANCER TREATMENT RESEARCH $143,941 Yes 0
93.988 COOPERATIVE AGREEMENTS FOR DIABETES CONTROL PROGRAMS $130,828 Yes 0
47.070 COMPUTER AND INFORMATION SCIENCE AND ENGINEERING $118,438 Yes 0
93.173 RESEARCH RELATED TO DEAFNESS AND COMMUNICATION DISORDERS $110,988 Yes 0
93.113 ENVIRONMENTAL HEALTH $110,013 Yes 0
93.914 HIV EMERGENCY RELIEF PROJECT GRANTS $105,387 Yes 0
93.394 CANCER DETECTION AND DIAGNOSIS RESEARCH $100,701 Yes 0
93.307 MINORITY HEALTH AND HEALTH DISPARITIES RESEARCH $91,688 Yes 0
93.399 CANCER CONTROL $89,401 Yes 0
93.286 DISCOVERY AND APPLIED RESEARCH FOR TECHNOLOGICAL INNOVATIONS TO IMPROVE HUMAN HEALTH $85,257 Yes 0
93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH $75,924 Yes 0
93.839 BLOOD DISEASES AND RESOURCES RESEARCH $75,425 Yes 0
93.350 NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES $60,187 Yes 0
93.213 RESEARCH AND TRAINING IN COMPLEMENTARY AND INTEGRATIVE HEALTH $59,427 Yes 0
93.397 CANCER CENTERS SUPPORT GRANTS $59,158 Yes 0
93.959 BLOCK GRANTS FOR PREVENTION AND TREATMENT OF SUBSTANCE ABUSE $56,997 Yes 0
93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING $55,360 Yes 0
17.804 LOCAL VETERANS' EMPLOYMENT REPRESENTATIVE PROGRAM $49,647 Yes 0
64.RD3 RESEARCH AND DEVELOPMENT $43,683 Yes 0
93.RD9 RESEARCH AND DEVELOPMENT $43,165 Yes 0
12.300 BASIC AND APPLIED SCIENTIFIC RESEARCH $39,785 Yes 0
93.353 21ST CENTURY CURES ACT - BEAU BIDEN CANCER MOONSHOT $32,889 Yes 0
93.067 GLOBAL AIDS $32,197 Yes 0
93.989 INTERNATIONAL RESEARCH AND RESEARCH TRAINING $31,499 Yes 0
93.172 HUMAN GENOME RESEARCH $31,413 Yes 0
93.866 AGING RESEARCH $27,674 Yes 0
93.926 HEALTHY START INITIATIVE $25,704 Yes 0
93.226 RESEARCH ON HEALTHCARE COSTS, QUALITY AND OUTCOMES $22,580 Yes 0
93.879 MEDICAL LIBRARY ASSISTANCE $20,523 Yes 0
93.837 CARDIOVASCULAR DISEASES RESEARCH $18,270 Yes 0
12.750 UNIFORMED SERVICES UNIVERSITY MEDICAL RESEARCH PROJECTS $16,047 Yes 0
93.396 CANCER BIOLOGY RESEARCH $13,582 Yes 0
97.036 DISASTER GRANTS - PUBLIC ASSISTANCE (PRESIDENTIALLY DECLARED DISASTERS) $12,015 Yes 0
93.279 DRUG USE AND ADDICTION RESEARCH PROGRAMS $11,971 Yes 0
93.243 SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES PROJECTS OF REGIONAL AND NATIONAL SIGNIFICANCE $7,533 Yes 0
93.398 CANCER RESEARCH MANPOWER $6,603 Yes 0
12.RD1 RESEARCH AND DEVELOPMENT $6,497 Yes 0
47.075 SOCIAL, BEHAVIORAL, AND ECONOMIC SCIENCES $5,877 Yes 0
47.041 ENGINEERING $5,542 Yes 0
93.103 FOOD AND DRUG ADMINISTRATION RESEARCH $5,422 Yes 0
98.001 USAID FOREIGN ASSISTANCE FOR PROGRAMS OVERSEAS $5,306 Yes 0
93.110 SPECIAL PROJECTS OF REGIONAL AND NATIONAL SIGNIFICANCE $5,000 Yes 0
93.233 NATIONAL CENTER ON SLEEP DISORDERS RESEARCH $4,173 Yes 0
93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH $3,363 Yes 0
93.393 CANCER CAUSE AND PREVENTION RESEARCH $3,229 Yes 0
93.361 NURSING RESEARCH $2,727 Yes 0
47.084 TECHNOLOGY, INNOVATION, AND PARTNERSHIPS $2,064 Yes 0
93.426 THE NATIONAL CARDIOVASCULAR HEALTH PROGRAM $2,000 Yes 0
93.840 TRANSLATION AND IMPLEMENTATION SCIENCE RESEARCH FOR HEART, LUNG, BLOOD DISEASES, AND SLEEP DISORDERS $1,871 Yes 0
93.RD4 RESEARCH AND DEVELOPMENT $1,253 Yes 0
93.RD7 RESEARCH AND DEVELOPMENT $1,067 Yes 0
93.RD6 RESEARCH AND DEVELOPMENT $45 Yes 0
93.360 BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA), BIODEFENSE MEDICAL COUNTERMEASURE DEVELOPMENT $-204 Yes 0
43.007 SPACE OPERATIONS $-299 Yes 0
16.320 SERVICES FOR TRAFFICKING VICTIMS $-959 Yes 0
93.351 RESEARCH INFRASTRUCTURE PROGRAMS $-1,371 Yes 0
93.838 LUNG DISEASES RESEARCH $-176,444 Yes 0

Contacts

Name Title Type
C1CPANL3EWK4 Jarod Kohr Auditee
6172167479 Jayme Silva Auditor
No contacts on file

Notes to SEFA

The schedule of expenditures of federal awards (the Schedule) presents the activity of all federal awards of Beth Israel Lahey Health, Inc. and Affiliates (BILH). All federal awards received directly from federal agencies, as well as federal awards passed through other agencies, are included on the Schedule.
The accompanying Schedule is presented using the cash basis of accounting. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulation Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Negative amounts shown on the Schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years.
Indirect costs are charged to federal grants and contracts at a federally approved predetermined rate. The predetermined rates for BILH and its affiliates range from 32%-72.9% for on-campus research for the fiscal year September 30, 2023, based on direct salaries and wages. BILH has not elected to utilize the 10% deminimus indirect cost rate in Part 200.514 of the Uniform Guidance.

Finding Details

BETH ISRAEL LAHEY HEALTH, INC. AND AFFILIATES Schedule of Findings and Questioned Costs Year ended September 30, 2025 Criteria: Title 2 U.S. Code of Federal Regulations Part 200 (2 CFR 200) Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards, Section 200.430(a) states that compensation for personal services includes all remuneration, paid currently or accrued, for services of employees rendered during the period of performance under the Federal award, including but not necessarily limited to wages and salaries. Costs of compensation are allowable to the extent the compensation is reasonable for the services rendered and conforms to the established written policy of the recipient or subrecipient consistently applied to both Federal and non-Federal activities; follows an appointment made in accordance with the recipient's or subrecipient's laws, rules, or written policies and meets the requirements of Federal statute, where applicable; and is determined and supported by records that accurately reflect the work performed. 2 CFR 200.403(b) further states costs must meet the criteria of conforming to any limitations or exclusions set forth in these principles or in the Federal award as to types or amount of cost items to be allowable under Federal awards. This includes the auditor to determine if the awards contain any negotiated wage or salary rates, or contain any restrictions on salaries and wages, such as the NIH restriction on the amount that may be charged for individual salaries (https://grants.nih.gov/grants/policy/salcap_summary.htm). Additionally, 2 CFR 200.400(d) requires the accounting practices of the recipient and subrecipient to be consistent with the cost principles and support the accumulation of costs as required by the cost principles, including maintaining adequate documentation to support costs charged to the Federal award. Furthermore, 2 CFR 200.403 states the factors affecting allowability of costs. These factors include the cost to (a) be necessary and reasonable for the performance of the Federal award and be allocable thereto under these principes and (g) be adequately documented to meet the criteria to be allowable under Federal awards. In addition, 2 CFR 200.303 requires nonfederal entities to, among other things, establish and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. Condition: During our testing of payroll for Beth Israel Deaconess Medical Center (BIDMC), an affiliate of Beth Israel Lahey Health, Inc., management did not consistently adhere to the specific award conditions set forth in the Notice of Award (NOA) related to salary limitations for 1 out of 12 of our samples related to our testing. The control operator applied an erroneous National Institutes of Health (NIH) Salary Cap limit when calculating the payroll allocation for an individual’s time allocated to a specific NIH grant selected for testing. As a result, the portion of the individual’s salary charged to the federal grant exceeded the maximum allowable NIH Salary Cap, resulting in an unallowable cost of $41 charged to the award. Furthermore, Joslin Diabetes Center (the Center), an affiliate of Beth Israel Lahey Health, Inc., manually matches purchase orders to the corresponding invoice once received. During our testing for 1 out of 25, we identified an invoice that was incorrectly matched to the purchase order for the Federal award selected for testing. This invoice was processed for payment and subsequently included in the monthly reimbursement draw. At the time of testing, the correct invoice corresponding to the valid purchase order for the selected grant had not yet been received by the Center. This resulted in the expenditure in the amount of $14 being BETH ISRAEL LAHEY HEALTH, INC. AND AFFILIATES Schedule of Findings and Questioned Costs Year ended September 30, 2025 allocated to the incorrect Federal award as well as the Federal award charged not being supported by adequate documentation. Cause: The conditions results from a lack of effective operation of internal controls over the allowability of costs related to Federal awards; specifically, ensuring the cost conforms to any limitations set forth in the Federal award as to the amount of cost items at BIDMC as well as ensuring the cost is allocable to the Federal grant and is adequately documented at the Center. Possible Asserted Effect: Failure to maintain sufficient internal controls to ensure a cost is allowable to a Federal award may result in unallowable costs being charged to Federal awards. Questioned Costs: None. Statistical Sampling: The sample was not intended to be, and was not, a statistically valid sample. Identification of Whether the Audit Finding was a Repeat Finding: This is not a repeat finding. Recommendation: We recommend that BILH enhance its internal controls over Federal award expenditures to ensure, where applicable, all costs charged to Federal awards conform to any limitations or salary caps set forth in the Federal award agreement, are accurately allocated to the correct grant and are adequately documented.